Revised SPCs: Cellcept (mycophenolate mofetil) preparations

SPC updated to note that mycophenolic acid has a cytostatic effect on B- and T-lymphocytes, therefore an increased severity of COVID-19 may occur. Dose reduction or discontinuation should be considered for patients in cases of clinically significant COVID-19.

Source:

electronic Medicines compendium